AP
LOXO

AHL Partners’s Loxo Oncology, Inc LOXO Stock Holding History

AHL Partners’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$202K Sell
2,395
-2,746
-53% -$229K ﹤0.01% 1215
2017
Q3 		$474K Buy
+5,141
New +$399K 0.01% 1067

Other funds holding LOXO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

AHL Partners's LOXO Position: Q4 2017 in Review

AHL Partners reduced its Loxo Oncology, Inc (LOXO) stake by 53% in Q4 2017, selling an estimated $229K and leaving 2,395 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #1215.

AHL Partners first reported a position in LOXO in Q3 2017 and has held it in 2 quarters since. The position peaked at $474K in Q3 2017. 141 funds tracked by Wall St. Rank hold LOXO as of Q4 2017.

  • AHL Partners held 2,395 shares of Loxo Oncology, Inc worth $202K as of Q4 2017.
  • AHL Partners sold 2,746 Loxo Oncology, Inc shares in Q4 2017, an estimated $229K.
  • Loxo Oncology, Inc made up ﹤0.01% of AHL Partners's portfolio in Q4 2017, its #1215 holding.
  • AHL Partners first reported a position in Loxo Oncology, Inc in Q3 2017 and has held it in 2 quarters since.
  • AHL Partners's Loxo Oncology, Inc position peaked at $474K in Q3 2017.
  • 141 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.